BIOVIE INC. Logo

BIOVIE INC.

Develops drug therapies for Alzheimer's, Parkinson's, and advanced liver diseases by targeting inflammation.

BIVI | US

Overview

Corporate Details

ISIN(s):
US09074F4054
LEI:
Country:
United States of America
Address:
680 W NYE LANE, 89703 CARSON CITY
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioVie Inc. is a clinical-stage biopharmaceutical company developing innovative drug therapies for chronic debilitating conditions, with a primary focus on neurological, neurodegenerative, and advanced liver diseases. The company's scientific approach posits that inflammation is a central factor in the progression of these disorders. Its lead therapeutic candidate, bezisterim, is a novel molecule being studied for the treatment of Alzheimer's and Parkinson's disease, aiming to modulate inflammation and enhance brain energy transfer. BioVie is also developing treatments for ascites, a common and life-threatening complication of advanced liver cirrhosis. The company's research incorporates advanced science, including the study of epigenetic mechanisms like DNA methylation to regulate gene expression.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BIOVIE INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOVIE INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOVIE INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

QuidelOrtho Corp Logo
Manufactures in-vitro diagnostic tests for at-home, point-of-care, and clinical lab settings.
United States of America
QDEL
Quince Therapeutics, Inc. Logo
Late-stage biotech developing red blood cell-encapsulated drugs for rare diseases.
United States of America
QNCX
Quoin Pharmaceuticals, Ltd. Logo
Clinical-stage pharma developing therapies for rare and orphan diseases like Netherton Syndrome.
United States of America
QNRX
Quratis Inc. Logo
Develops infectious disease vaccines and offers biologics CDMO services for global health.
South Korea
348080
Radiopharm Theranostics Ltd Logo
Developing first-in-class radiopharmaceuticals for the diagnosis and treatment of cancer.
United States of America
RADX
Rallybio Corp Logo
Develops therapies for severe and rare diseases in hematology and complement dysregulation.
United States of America
RLYB
Rani Therapeutics Holdings, Inc. Logo
Develops a capsule to convert injectable biologics into oral pills for chronic diseases.
United States of America
RANI
Rapport Therapeutics, Inc. Logo
Developing precision small molecule medicines for Central Nervous System (CNS) disorders.
United States of America
RAPP
RAPT Therapeutics, Inc. Logo
Developing immune-targeting therapies for inflammatory and immunologic diseases.
United States of America
RAPT
Recordati Industria Chimica e Farmaceutica Logo
Global pharma group developing drugs for common/rare diseases & supplying APIs worldwide.
Italy
REC

Talk to a Data Expert

Have a question? We'll get back to you promptly.